Xeris Biopharma Annual Report 2022: A Comprehensive Overview

Jeremy Jul 21, 2026

Dive into the latest fiscal year with Xeris Biopharma's annual report, a comprehensive chronicle of our progress, milestones, and mission to transform lives through innovative, ready-to-use, liquid medicine. As we wind down 2021, our commitment to enhancing patients' access to critical medicines remains unyielding.

Medical Cover Design, Hospital Poster, Organizational Chart Design, Presentation Format, Powerpoint Layout, Effective Presentation, Organizational Chart, Medical Posters, Visual Aids
Medical Cover Design, Hospital Poster, Organizational Chart Design, Presentation Format, Powerpoint Layout, Effective Presentation, Organizational Chart, Medical Posters, Visual Aids

The annual report is not just a financial overview; it's a testament to our dedication to improving healthcare and a roadmap for our future. Let's delve into the happenings of 2021, our strategic initiatives, and the upcoming years.

an annual report with polar bears and ships
an annual report with polar bears and ships

Financial Milestones and Growth

Fiscal 2021 brought significant financial milestones, reflecting our expanding scope and reach. We witnessed a 36% increase in total revenue, driven largely by the success of our lead product, Gvoke, and strategic partnerships.

an open book with different types of text on it and numbers in the bottom right corner
an open book with different types of text on it and numbers in the bottom right corner

Our research and development expenses also surged, reflecting our commitment to advancing our pipeline. This increase aligns with our long-term vision to diversify our portfolio and broaden our therapeutic focus.

Commercial Excellence

an annual report cover with several people in circles
an annual report cover with several people in circles

Our commercial strategies yielded commendable results, with Gvoke's market penetration expanding significantly. Thanks to our reimbursement strategies and market access efforts, more patients than ever before have access to our lifesaving medicine.

Our expansion into new markets, namely diabetes specialty pharmacies, further bolstered our reach. Initiatives like our 'Access for All' program underscored our commitment to ensuring affordability for uninsured and underinsured patients.

.Product Pipeline Progress

Creative Business Annual Report
Creative Business Annual Report

Our late-stage pipeline flourished in 2021. We advanced[X] through two Phase 3 clinical trials, bringing us closer to potential new treatments for critical conditions. We also expandedinto new indications for Gvoke, further demonstrating the versatility of our platform.

Additionally, our earlier-stage pipeline made significant strides. We initiated Phase 2 trials for[Y] and [Z], and pre-clinical programs like[W] showed promising results, contributing to our robust pipeline.

Partnerships and Collaborations

Klim Type Foundry · Fonts in use · Xero Annual Report 2018
Klim Type Foundry · Fonts in use · Xero Annual Report 2018

Strategic collaborations and partnerships lie at the heart of our success. In 2021, we inked a strategic agreement with a leading pharmaceutical company to expedite the development and commercialization of our ready-to-use liquid products.

We also bolstered our presence in the rare disease space through a collaboration with a preeminent advocacy organization. Together, we aim to improve access to care and treatments for patients with rare diseases.

Agrium Annual Report - Joel Harding
Agrium Annual Report - Joel Harding
the brochure is designed to look like it has green leaves on it
the brochure is designed to look like it has green leaves on it
12 Premium Templates for Professional Annual Report Brochures
12 Premium Templates for Professional Annual Report Brochures
BVE annual report - EIGA
BVE annual report - EIGA
an image of what happens before it reaches you info graphic on the bottom right hand corner
an image of what happens before it reaches you info graphic on the bottom right hand corner
Annual report design – Design and rebranding agency — Navig8
Annual report design – Design and rebranding agency — Navig8
Annual Report Projects :: Photos, videos, logos, illustrations and branding
Annual Report Projects :: Photos, videos, logos, illustrations and branding
a brochure with images of people working in laboratorys and other things on it
a brochure with images of people working in laboratorys and other things on it
Showcase of Diverse Annual Report Projects: Graphics, Videos & Brandin
Showcase of Diverse Annual Report Projects: Graphics, Videos & Brandin
NIS Annual Report | Metaklinika
NIS Annual Report | Metaklinika
Healthcare KPI Report Brochure Template
Healthcare KPI Report Brochure Template
Conceptual Annual Report — Department of Conservation - Tamsen Bourgeois
Conceptual Annual Report — Department of Conservation - Tamsen Bourgeois
reference
reference
手册
手册
QIMR Berghofer
QIMR Berghofer
the cover of an annual report on china's innovative medical information technology, 2013
the cover of an annual report on china's innovative medical information technology, 2013
a book with an image of a woman wearing a surgical mask
a book with an image of a woman wearing a surgical mask
an open book with yellow and black circles
an open book with yellow and black circles
brosch
brosch
Whitepaper Report Template
Whitepaper Report Template

Investing in Our Future

We expanded our workforce, welcoming talented individuals who share our passion for transforming medicine. We also invested in our infrastructure, moving into a new, state-of-the-art facility to support our growing operations.

Moreover, we fortified our balance sheet with a successful public offering, ensuring we have the financial resources to execute our growth strategy and advance our pipeline.

As we turn our gaze to 2022, we look forward to building on our momentum. The road ahead holds promising milestones, including regulatory submissions, product launches, and further pipeline advancements. Stay tuned for more updates from Xeris Biopharma.